diazoxide has been researched along with cardiovascular agents in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bast, P; Dzeja, PP; Holmuhamedov, EL; Ozcan, C; Terzic, A; Valverde, A; Van Wylen, DG | 1 |
| Imamura, H; Nakao, S; Otani, H; Shingu, K; Uchiyama, Y; Wakeno-Takahashi, M | 1 |
| Campbell, WB; Falck, JR; Gauthier, KM; Gross, GJ; Hammock, BD; Moore, J; Nithipatikom, K | 1 |
| Biernat, J; Bończyk, A; Deja, MA; Domaradzki, W; Gołba, KS; Hudziak, D; Kajor, M; Lebda-Wyborny, T; Malinowski, M; Szurlej, D; Woś, S | 1 |
| Carrillo, ED; García, MC; Hernández, A; Narasimhan, G; Sánchez, JA | 1 |
1 trial(s) available for diazoxide and cardiovascular agents
| Article | Year |
|---|---|
Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxide-supplemented cardioplegia.
Topics: Aged; Cardioplegic Solutions; Cardiovascular Agents; Coronary Artery Bypass; Coronary Artery Disease; Diazoxide; Double-Blind Method; Feasibility Studies; Female; Heart; Heart Arrest, Induced; Hemodynamics; Humans; Male; Middle Aged; Mitochondria, Heart; Myocardium; Ventricular Function, Left | 2009 |
4 other study(ies) available for diazoxide and cardiovascular agents
| Article | Year |
|---|---|
Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amides; Animals; Cardiovascular Agents; Decanoic Acids; Diazoxide; Electron Transport; Flavin-Adenine Dinucleotide; Hydroxy Acids; Ischemic Preconditioning; Kinetics; Malondialdehyde; Mitochondria, Heart; Nucleotides; Oxidative Stress; Rats; Reactive Oxygen Species; Succinate Dehydrogenase; Succinates; Superoxides | 2003 |
Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms.
Topics: Adenosine; Anesthetics, Inhalation; Animals; Cardiovascular Agents; Diazoxide; Dose-Response Relationship, Drug; Flavoproteins; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Isoflurane; Male; Membrane Proteins; Mitochondria, Heart; Myocardial Infarction; Nitric Oxide Donors; Oxidation-Reduction; Potassium Channels; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine | 2004 |
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Blood Pressure; Cardiovascular Agents; Coronary Circulation; Diazoxide; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epoxide Hydrolases; Female; Heart Rate; Lauric Acids; Male; Mitochondria, Heart; Myocardial Infarction; Myocardium; Potassium Channels | 2008 |
Protective Action of Diazoxide on Isoproterenol-Induced Hypertrophy Is Mediated by Reduction in MicroRNA-132 Expression.
Topics: Animals; Animals, Newborn; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Cyclic AMP Response Element-Binding Protein; Diazoxide; Disease Models, Animal; Isoproterenol; Male; MicroRNAs; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Oxidative Stress; Phosphorylation; Rats, Wistar; Reactive Oxygen Species; Signal Transduction | 2018 |